Clinical Trials in Jingjiang, China
2 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Chronic Kidney DiseaseAtherosclerosis Cardiovascular Disease
Eli Lilly and Company7,140 enrolled568 locationsNCT07241390
Recruiting
Phase 3
Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder
Insomnia Disorder
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.1,041 enrolled88 locationsNCT05525637
Recruiting
A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis
Radiation Pneumonitis
Huazhong University of Science and Technology300 enrolled3 locationsNCT05448703